stigma - Page 1 | CARLAT PUBLISHING

Expert Q&A

Breaking the Stigma: Helping Physicians Seek and Sustain Recovery

July 1, 2025

Dr. Peter Grinspoon is a primary care physician and cannabis specialist at Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School, Boston, MA. Author of Free Refills: A Doctor Confronts His Addiction (Hachette Books, 2016) and Seeing Through the Smoke: A Cannabis Specialist Untangles the Truth About Marijuana (Prometheus, 2023).

Dr. Grinspoon has no financial relationships with companies related to this material.

Dr. Peter Grinspoon reflects on his own recovery from opioid addiction and the barriers that keep doctors from seeking help. He shares personal insights and evidence-based strategies for supporting physician recovery and makes the case for a more compassionate, flexible model of care and monitoring.

Clinical Update

Neuroscience-Based Nomenclature: Significance to Psychiatrists

September 3, 2024

Heidi Moawad, MD and Chris Aiken, MD

Heidi Moawad, MD. Neurologist and teaching faculty, Case Western Reserve University School of Medicine.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

The authors have no financial relationships with companies related to this material.

NbN helps to address stigma by emphasizing the pharmacological properties of medications rather than terms that may lead to misunderstandings among patients and their families

CLINICAL UPDATE

What Is Neuroscience-Based Nomenclature?

April 1, 2024

Heidi Moawad, MD

Heidi Moawad, MD. Clinical assistant professor, Case Western Reserve School of Medicine, Cleveland, OH.

Dr. Moawad has no financial relationships with companies related to this material.

Tired of patients and families who react to categories of medications with confusion and fear? We use ‘antidepressants’ for OCD, and ‘antipsychotics’ for irritability. These are not accurate descriptions. Our clinical update on Neurocience-Based Nomenclature will help you use NbN to clarify your treatment plans and reduce stigma for patients and families.

Addressing Weight Stigma in Clinical Practice

September 19, 2022

Joshua Feder, MD and Mara Goverman

Every patient and family you see is inescapably impacted by weight stigma or fat shaming and the damage from this bias can lethal.

EXPERT Q&A

Addressing Weight Stigma in Clinical Practice

July 1, 2022

Sarah Nutter, PhD

Sarah Nutter, PhD

Assistant professor, Department of Educational Psychology and Leadership Studies, University of Victoria, BC, Canada. Member of EveryBODY Matters, a multidisciplinary partnership of weight bias and obesity stigma researchers engaging in advocacy and outreach.

Dr. Nutter has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Every patient and family you see is inescapably impacted by weight stigma or fat shaming and the damage from this bias can lethal. Our interview with Dr. Sarah Nutter unpacks this cultural conundrum and helps you counterbalance the stigma and help your patients to shield themselves from weight stigma with healthier attitudes.

Electroconvulsive Therapy: A Primer

March 23, 2022

Stephen J. Seiner, MD

Stephen J. Seiner, MD Director of neurotherapeutics, McLean Hospital. Belmont, MA. Dr. Seiner has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Seiner runs one of the busiest ECT programs in the country and speaks to us about recent innovations in the procedure. He also tells us which patients are the best candidates and shares tips for how to prolong ECT’s benefits.

Overdiagnosis in Psychiatry

September 10, 2021

Joel Paris, MD

Joel Paris, MD

Professor emeritus at McGill University, and senior psychiatrist and research associate at Sir Mortimer B. Davis-Jewish General Hospital. Dr. Paris is the former editor of the Canadian Journal of Psychiatry and the author of 25 books including Overdiagnosis in Psychiatry, 2nd ed. (Oxford University Press; 2020). Dr. Paris has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Joel Paris explains why adult ADHD, depression, bipolar II, PTSD, and borderline personality are overdiagnosed in psychiatry at the expense of schizophrenia.

EXPERT Q&A

Communicating With Patients About Gender

August 5, 2020

Alex Keuroghlian, MD, MPH

Alex Keuroghlian, MD, MPH

Director, National LGBT Health Education Center at The Fenway Institute; Director, Massachusetts General Hospital Department of Psychiatry Gender Identity Program; Associate Professor, Harvard Medical School Dr. Keuroghlian has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What are the risks for depression and suicide with transgender patients and how can we provide the best care for them? Alex Keuroghlian, MD, MPH, answers that question and more.

Reducing the Stigma of Addiction Through Language and Terminology

March 30, 2020

Specific terms and phrases, when used among health professionals, can lead to more punitive treatment plans and increased stigma perceived by patients. Learn the evidence base behind recent recommendations among medical societies, journals, and periodicals to use more person-centered language.

Stigmatizing Smoking: An Effective Deterrent?

March 30, 2020

Benjamin Oldfield, MD

Benjamin Oldfield, MD Dr. Oldfield has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In a randomized controlled trial, researchers tested a statement that invokes shame in people who smoke cigarettes and measured how it impacts the time until they smoke the next cigarette.